findmyKOL
Clinical trialNCT02006576CompletedPhase 2Interventional

Prostaglandin Inhibition for Emphysema

SponsorUniversity of NebraskaEnrollment118Emphysema
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The Prostaglandin Inhibition for Emphysema (PIE) study will determine if a currently available therapy, ibuprofen 600 mg three times daily, can block PGE production in the lower respiratory tract and if this results in improvement in measures of lung repair function.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Alabama at Birmingham

    Birmingham, Alabama, United States

  • Harbor-Ucla Medical Center

    Torrance, California, United States

  • National Jewish Health

    Denver, Colorado, United States

  • Univerisity of Nebraska Medical Center

    Omaha, Nebraska, United States

  • Temple University

    Philadelphia, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

600 mg ibuprofen three times daily for 48 weeks
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Jan 2014
Primary completion
31 Mar 2018
Completion
31 Mar 2018
Last update posted
13 Dec 2023
Registered enrollment
118
Registry id
NCT02006576

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.